These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 17600150)

  • 1. Solution structure of the general transcription factor 2I domain in mouse TFII-I protein.
    Doi-Katayama Y; Hayashi F; Inoue M; Yabuki T; Aoki M; Seki E; Matsuda T; Kigawa T; Yoshida M; Shirouzu M; Terada T; Hayashizaki Y; Yokoyama S; Hirota H
    Protein Sci; 2007 Aug; 16(8):1788-92. PubMed ID: 17600150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple GTF2I-like repeats of general transcription factor 3 exhibit DNA binding properties. Evidence for a common origin as a sequence-specific DNA interaction module.
    Vullhorst D; Buonanno A
    J Biol Chem; 2005 Sep; 280(36):31722-31. PubMed ID: 15987678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solution structure of the RWD domain of the mouse GCN2 protein.
    Nameki N; Yoneyama M; Koshiba S; Tochio N; Inoue M; Seki E; Matsuda T; Tomo Y; Harada T; Saito K; Kobayashi N; Yabuki T; Aoki M; Nunokawa E; Matsuda N; Sakagami N; Terada T; Shirouzu M; Yoshida M; Hirota H; Osanai T; Tanaka A; Arakawa T; Carninci P; Kawai J; Hayashizaki Y; Kinoshita K; Güntert P; Kigawa T; Yokoyama S
    Protein Sci; 2004 Aug; 13(8):2089-100. PubMed ID: 15273307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic organization of the genes Gtf2ird1, Gtf2i, and Ncf1 at the mouse chromosome 5 region syntenic to the human chromosome 7q11.23 Williams syndrome critical region.
    Bayarsaihan D; Dunai J; Greally JM; Kawasaki K; Sumiyama K; Enkhmandakh B; Shimizu N; Ruddle FH
    Genomics; 2002 Jan; 79(1):137-43. PubMed ID: 11827466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GTF2IRD2 is located in the Williams-Beuren syndrome critical region 7q11.23 and encodes a protein with two TFII-I-like helix-loop-helix repeats.
    Makeyev AV; Erdenechimeg L; Mungunsukh O; Roth JJ; Enkhmandakh B; Ruddle FH; Bayarsaihan D
    Proc Natl Acad Sci U S A; 2004 Jul; 101(30):11052-7. PubMed ID: 15243160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of a mouse model for a conditional inactivation of Gtf2i allele.
    Enkhmandakh B; Stoddard C; Mack K; He W; Kaback D; Yee SP; Bayarsaihan D
    Genesis; 2016 Jul; 54(7):407-12. PubMed ID: 27194223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Domain architecture of the p62 subunit from the human transcription/repair factor TFIIH deduced by limited proteolysis and mass spectrometry analysis.
    Jawhari A; Boussert S; Lamour V; Atkinson RA; Kieffer B; Poch O; Potier N; van Dorsselaer A; Moras D; Poterszman A
    Biochemistry; 2004 Nov; 43(45):14420-30. PubMed ID: 15533047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solution structure of the carboxyl-terminal domain of RAP74 and NMR characterization of the FCP1-binding sites of RAP74 and human TFIIB.
    Nguyen BD; Chen HT; Kobor MS; Greenblatt J; Legault P; Omichinski JG
    Biochemistry; 2003 Feb; 42(6):1460-9. PubMed ID: 12578358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure of the nuclear factor ALY: insights into post-transcriptional regulatory and mRNA nuclear export processes.
    Pérez-Alvarado GC; Martínez-Yamout M; Allen MM; Grosschedl R; Dyson HJ; Wright PE
    Biochemistry; 2003 Jun; 42(24):7348-57. PubMed ID: 12809490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Solution structure of the peptidoglycan binding domain of Bacillus subtilis cell wall lytic enzyme CwlC: characterization of the sporulation-related repeats by NMR.
    Mishima M; Shida T; Yabuki K; Kato K; Sekiguchi J; Kojima C
    Biochemistry; 2005 Aug; 44(30):10153-63. PubMed ID: 16042392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The EH1 domain of Eps15 is structurally classified as a member of the S100 subclass of EF-hand-containing proteins.
    Whitehead B; Tessari M; Carotenuto A; van Bergen en Henegouwen PM; Vuister GW
    Biochemistry; 1999 Aug; 38(35):11271-7. PubMed ID: 10471276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure of the central core domain of TFIIEbeta with a novel double-stranded DNA-binding surface.
    Okuda M; Watanabe Y; Okamura H; Hanaoka F; Ohkuma Y; Nishimura Y
    EMBO J; 2000 Mar; 19(6):1346-56. PubMed ID: 10716934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural comparison of the PhoB and OmpR DNA-binding/transactivation domains and the arrangement of PhoB molecules on the phosphate box.
    Okamura H; Hanaoka S; Nagadoi A; Makino K; Nishimura Y
    J Mol Biol; 2000 Feb; 295(5):1225-36. PubMed ID: 10653699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TFII-I regulates target genes in the PI-3K and TGF-β signaling pathways through a novel DNA binding motif.
    Segura-Puimedon M; Borralleras C; Pérez-Jurado LA; Campuzano V
    Gene; 2013 Sep; 527(2):529-36. PubMed ID: 23831514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solution structure of the yeast URN1 splicing factor FF domain: comparative analysis of charge distributions in FF domain structures-FFs and SURPs, two domains with a similar fold.
    Bonet R; Ramirez-Espain X; Macias MJ
    Proteins; 2008 Dec; 73(4):1001-9. PubMed ID: 18536009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solution structure of component B from methane monooxygenase derived through heteronuclear NMR and molecular modeling.
    Chang SL; Wallar BJ; Lipscomb JD; Mayo KH
    Biochemistry; 1999 May; 38(18):5799-812. PubMed ID: 10231531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel solution structure of porcine beta-microseminoprotein.
    Wang I; Lou YC; Wu KP; Wu SH; Chang WC; Chen C
    J Mol Biol; 2005 Mar; 346(4):1071-82. PubMed ID: 15701518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NMR structure of the amino-terminal domain from the Tfb1 subunit of TFIIH and characterization of its phosphoinositide and VP16 binding sites.
    Di Lello P; Nguyen BD; Jones TN; Potempa K; Kobor MS; Legault P; Omichinski JG
    Biochemistry; 2005 May; 44(21):7678-86. PubMed ID: 15909982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathophysiology of TFII-I: Old Guard Wearing New Hats.
    Roy AL
    Trends Mol Med; 2017 Jun; 23(6):501-511. PubMed ID: 28461154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The early embryonic expression of TFII-I during mouse preimplantation development.
    Enkhmandakh B; Bitchevaia N; Ruddle F; Bayarsaihan D
    Gene Expr Patterns; 2004 Jan; 4(1):25-8. PubMed ID: 14678824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.